查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1787868

大腸桿菌檢測市場預測（至 2032 年）：按產品、檢測類型、技術、最終用戶和地區進行的全球分析

E-coli Testing Market Forecasts to 2032 - Global Analysis By Product (Consumables, Instruments, and Other Products), Test Type, Technology, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球大腸桿菌檢測市場預計在 2025 年達到 24.7 億美元，到 2032 年將達到 43.7 億美元，預測期內的複合年成長率為 8.5%。

大腸桿菌檢測是指檢測水、食品或其他樣本中的大腸桿菌，以確保安全和公共衛生的過程。它常用於環境監測、食品生產和臨床檢測，有助於識別可能導致疾病的污染。檢測方法包括膜過濾、酵素連結免疫吸附試驗和聚合酶鏈反應 (PCR)。準確的檢測有助於快速回應和補救，並確保符合安全標準和法規，從而防止疫情爆發。

研究表明，TaqPath 面板的敏感性和特異性超過 98%，可確保您獲得值得信賴的一致結果。

食物中毒增加

越來越多與受污染肉類、農產品和乳製品相關的疫情正在提高消費者和監管機構的意識。食品供應鏈的全球化進一步增加了大腸桿菌感染的風險，需要嚴格的檢測通訊協定。都市化和飲食習慣的改變（例如已調理食品消費量的增加）也加劇了風險。為此，各國政府正在加強監管，強制要求定期進行微生物檢測，而食品製造商也正在投資先進的檢測技術。總體而言，這些趨勢正在推動各行各業對有效的大腸桿菌檢測解決方案的需求。

先進測試技術高成本

PCR和DNA檢測等先進的診斷方法需要昂貴的設備、熟練的技術人員以及持續的維護，這使得中小型食品製造商難以獲得這些方法。這些經濟障礙阻礙了這些方法的廣泛應用，尤其是在醫療基礎設施和資金有限的開發中地區。此外，持續遵守嚴格的安全法規的成本也給企業帶來了負擔，阻礙了它們投資尖端檢測解決方案。因此，許多公司依賴傳統的、靈敏度較低的檢測方法，這可能會削弱大腸桿菌檢測的有效性，並減緩整體市場的成長。

提高醫療保健意識

嚴格的政府政策和國際衛生計劃強調衛生和食品安全的重要性，並提倡定期檢測。技術進步使大腸桿菌診斷工具更快、更準確、可得性，促進了其廣泛應用。此外，媒體關注度和公眾宣導活動的不斷提高，也造就了注重健康的消費者群體。同時，新興國家醫療基礎設施的不斷擴展，也使得檢測方法在臨床、環境和食品產業中廣泛應用。

缺乏熟練的專業人員和訓練有素的人員

準確的檢測需要掌握操作先進診斷設備和解讀複雜結果的專業知識，而這在許多地區，尤其是新興國家，都十分匱乏。這種人才短缺限制了先進檢測技術的採用，並影響了大腸桿菌檢測的整體品質和可靠性。此外，訓練不足阻礙了標準化檢測通訊協定的實施，導致結果不一致。合格人員的缺乏限制了市場的成長，因為它加劇了對傳統方法的依賴，減慢了檢測流程，並降低了大腸桿菌檢測服務的效率和擴充性。

COVID-19的影響：

新冠疫情最初擾亂了大腸桿菌檢測市場，原因是醫療資源轉移、實驗室關閉以及供應鏈中斷，人們的注意力轉向了病毒預防。在許多地區，常規食品安全和環境檢測被推遲或被降級。然而，這場疫情也提高了全球對感染疾病風險的認知，並凸顯了快速診斷的重要性。這導致對檢測基礎設施和衛生通訊協定的投資增加，最終增強了對可靠大腸桿菌檢測解決方案的長期需求。

臨床測試部分預計將成為預測期內最大的部分

由於大腸桿菌相關感染疾病率不斷上升，尤其是在兒童和老年人等弱勢群體中，臨床檢測領域預計將在預測期內佔據最大的市場佔有率。胃腸道感染疾病住院人數的增加推動了對準確及時診斷的需求。分子診斷技術的進步以及人們對抗菌素抗藥性認知的不斷提高，進一步鼓勵醫療保健提供者採用準確的實驗室檢測方法，以有效管理患者並控制感染。

預計在預測期內，醫院和診所部門的複合年成長率最高。

預計醫院和診所細分市場將在預測期內實現最高成長率，這得益於患者入院人數的增加，尤其是在急診和小兒科，以及對快速準確診斷的需求不斷成長。分子PCR檢測板和人工智慧增強型工作流程的採用，可以加快治療決策的速度。此外，臨床環境中的感染控制通訊協定和抗生素管理計畫也進一步鼓勵定期篩檢大腸桿菌，以預防疫情爆發並改善病患預後。

比最大的地區

預計亞太地區將在預測期內佔據最大的市場佔有率，這得益於人們對食品安全的日益關注、醫療保健體系的不斷完善以及公眾對水傳播感染疾病認知的不斷提高。中國和印度等國家的城市人口成長和人口結構變化正在推動對高效診斷工具的需求。政府的支援政策和健康宣傳活動鼓勵定期檢測，而PCR和生物感測器技術的創新正在提高檢測速度和準確性，從而促進其在醫療保健和環境領域的應用。

複合年成長率最高的地區：

預計北美在預測期內的複合年成長率最高。這得益於嚴格的食品安全法規、健全的醫療保健體係以及人們對微生物威脅日益成長的認知。頻繁的污染事件和對快速診斷的需求，促使人們採用PCR和LAMP等尖端方法。雖然FDA等機構的監管標準很高，但食品製造和水資源管理等關鍵產業也注重持續監測，以維護食品安全並保護消費者。

免費客製化服務：

此報告的訂閱者可以從以下免費自訂選項中選擇一項：

  • 公司簡介
    • 對最多三家其他市場公司進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 二手研究資料
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球大腸桿菌檢測市場（按產品）

  • 耗材
  • 裝置
  • 其他產品

6. 全球大腸桿菌檢測市場（依檢測類型）

  • 環境檢查
    • 水質檢測
      • 薄膜過濾
      • 多管發酵（MTF）
      • 酵素基材法
    • 食品和飲料檢驗
    • 動物飼料和牲畜檢驗
  • 實驗室檢查
    • 聚合酵素鏈鎖反應（PCR）
    • 酵素免疫分析法（EIA）
    • 基於文化的方法
    • 快速診斷測試
    • 分子檢測
  • 其他類型的測試

7. 全球大腸桿菌檢測市場（依技術）

  • 生物感測器
  • 層析法平台
  • 質譜儀系統
  • 凝膠微滴法
  • 動態光散射
  • 流式細胞技術
  • 診斷影像
  • 其他技術

8. 全球大腸桿菌檢測市場（依最終用戶）

  • 診斷實驗室
  • 醫院和診所
  • 食品加工公司
  • 水和污水處理
  • 政府和公共衛生機構
  • 研究和學術機構
  • 醫生診所
  • 其他最終用戶

9. 全球大腸桿菌檢測市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章：主要發展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • Abbott Laboratories
  • Siemens
  • Beckman Coulter
  • Hoffmann-La Roche
  • Wako
  • Cepheid
  • Becton, Dickinson and Company
  • Johnson & Johnson
  • Affymetrix
  • Novartis
  • bioMerieux
  • Olympus
  • Bio-Rad Laboratories
  • GenBio
  • Thermo Fisher Scientific
Product Code: SMRC30133

According to Stratistics MRC, the Global E-coli Testing Market is accounted for $2.47 billion in 2025 and is expected to reach $4.37 billion by 2032 growing at a CAGR of 8.5% during the forecast period. E-coli testing is the process of detecting Escherichia coli bacteria in water, food, or other samples to ensure safety and public health. Commonly used in environmental monitoring, food production, and clinical labs, it helps identify contamination that may lead to illness. Techniques include membrane filtration, enzyme-based assays, and PCR methods. Accurate testing prevents outbreaks by allowing quick response and remediation, ensuring compliance with safety standards and regulations.

According to a research article, the TaqPath panel provides sensitivity and specificity of over 98%, ensuring that the results are always dependable.

Market Dynamics:

Driver:

Rising incidence of foodborne illnesses

Increased outbreaks linked to contaminated meat, produce, and dairy products have heightened awareness among consumers and regulatory bodies. Globalization of the food supply chain further amplifies the risk of E. coli transmission, requiring stringent testing protocols. Urbanization and changing dietary habits, such as higher consumption of ready-to-eat foods, also contribute to the risk. In response, governments are enforcing stricter regulations and mandating routine microbial testing, while food producers invest in advanced detection technologies. These trends collectively propel the demand for effective E-coli testing solutions across various sectors.

Restraint:

High cost of advanced testing technologies

Sophisticated diagnostic methods, such as PCR and DNA-based assays, require expensive equipment, skilled technicians, and ongoing maintenance, making them less accessible to small and medium-sized food producers. These financial barriers hinder widespread adoption, especially in developing regions with limited healthcare infrastructure and funding. Additionally, the cost of continuous compliance with stringent safety regulations can be burdensome for businesses, reducing their willingness to invest in cutting-edge testing solutions. As a result, many organizations rely on traditional, less sensitive methods, potentially compromising the effectiveness of E. coli detection and slowing overall market growth.

Opportunity:

Increasing healthcare awareness

Strict government policies and international health initiatives stress the significance of hygiene and food safety, promoting regular testing practices. Advances in technology have improved the speed, accuracy, and availability of E. coli diagnostic tools, encouraging wider use. Moreover, greater media attention and public education efforts have led consumers to place more value on their health. At the same time, the expansion of healthcare infrastructure in developing countries is enabling broader adoption of testing procedures across clinical, environmental, and food industry applications.

Threat:

Lack of skilled professionals and trained personnel

Accurate testing requires expertise in handling advanced diagnostic equipment and interpreting complex results, which many regions, especially developing countries, lack. This shortage limits the adoption of sophisticated testing technologies and affects the overall quality and reliability of E-coli detection. Additionally, inadequate training hampers the implementation of standardized testing protocols, leading to inconsistent outcomes. The scarcity of qualified staff increases dependency on traditional methods, slows down testing processes, and restricts market growth by reducing the efficiency and scalability of E-coli testing services.

Covid-19 Impact:

The COVID-19 pandemic initially disrupted the E. coli testing market due to diverted healthcare resources, lab closures, and supply chain interruptions, as focus shifted to combating the virus. Routine food safety and environmental testing were delayed or deprioritized in many regions. However, the pandemic also heightened global awareness of infectious disease risks and emphasized the importance of rapid diagnostics. This led to increased investment in testing infrastructure and hygiene protocols, ultimately strengthening long-term demand for reliable E-coli testing solutions.

The clinical testing segment is expected to be the largest during the forecast period

The clinical testing segment is expected to account for the largest market share during the forecast period, due to the rising incidence of E. coli-related infections, particularly in vulnerable populations such as children and the elderly. Increased hospital admissions linked to gastrointestinal illnesses have heightened the need for accurate and timely diagnosis. Advancements in molecular diagnostics and growing awareness of antimicrobial resistance further push healthcare providers to adopt precise clinical testing methods for effective patient management and infection control.

The hospitals & clinics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals & clinics segment is predicted to witness the highest growth rate, due to rising patient admissions, especially in emergency and pediatric departments, increase demand for rapid and accurate diagnostics. Adoption of molecular PCR panels and AI-enhanced workflows enables faster treatment decisions. Additionally, infection control protocols and antimicrobial stewardship programs in clinical settings further promote routine E. coli screening to prevent outbreaks and improve patient outcomes.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, driven by increasing concerns about food safety, improved healthcare systems, and growing public awareness of waterborne illnesses. Rising urban populations and demographic shifts in nations like China and India have increased the need for efficient diagnostic tools. Supportive government policies and health campaigns encourage regular testing, while innovations in PCR and biosensor technologies enhance speed and precision, boosting uptake in both medical and environmental applications.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to strict food safety laws, robust healthcare systems, and growing awareness of microbial threats. Recurring contamination events and the need for swift diagnostics have spurred the uptake of cutting-edge methods such as PCR and LAMP. Oversight by agencies like the FDA maintains high regulatory benchmarks, while key sectors like food manufacturing and water management focus on continuous monitoring to uphold safety and protect consumers.

Key players in the market

Some of the key players in E-coli Testing Market include Abbott Laboratories, Siemens, Beckman Coulter, Hoffmann-La Roche, Wako, Cepheid, Becton, Dickinson and Company, Johnson & Johnson, Affymetrix, Novartis, bioMerieux, Olympus, Bio-Rad Laboratories, GenBio, and Thermo Fisher Scientific.

Key Developments:

In July 2025, Siemens Smart Infrastructure announced a collaboration agreement with Microsoft to transform access to Internet of Things (IoT) data for buildings. The collaboration will enable interoperability between Siemens' digital building platform, Building X, and Microsoft Azure IoT Operations enabled by Azure Arc.

In March 2025, Beckman Coulter Diagnostics announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer, received 510(k) clearance from the U.S. Food and Drug Administration. The DxC 500i combines advanced technology with an intuitive user interface, ensuring that laboratories of all sizes can meet the growing demands of modern healthcare.

In February 2025, Abbott expands longstanding partnership with shedd aquarium through $10 million donation. Abbott and Shedd Aquarium are announcing a $10 million pledge from Abbott and Abbott's philanthropic foundation, Abbott Fund. The investment cements the longstanding partnership between Shedd, Abbott, and Abbott Fund to enrich the cultural, educational and environmental fabric of Chicago and spark passion for protecting the ocean environment.

Products Covered:

  • Consumables
  • Instruments
  • Other Products

Test Types Covered:

  • Environmental Testing
  • Clinical Testing
  • Other Test Types

Technologies Covered:

  • Biosensors
  • Chromatography Platforms
  • Mass Spectrometry Systems
  • Gel Micro Droplets
  • Differential Light Scattering
  • Flow Cytometry
  • Diagnostic Imaging
  • Other Technologies

End Users Covered:

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Food Processing Companies
  • Water Utilities & Wastewater Treatment
  • Government & Public Health Agencies
  • Research & Academic Institutions
  • Physicians' Offices
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global E-coli Testing Market, By Product

  • 5.1 Introduction
  • 5.2 Consumables
  • 5.3 Instruments
  • 5.4 Other Products

6 Global E-coli Testing Market, By Test Type

  • 6.1 Introduction
  • 6.2 Environmental Testing
    • 6.2.1 Water Testing
      • 6.2.1.1 Membrane Filtration
      • 6.2.1.2 Multiple Tube Fermentation (MTF)
      • 6.2.1.3 Enzyme Substrate Methods
    • 6.2.2 Food & Beverage Testing
    • 6.2.3 Animal Feed & Livestock Testing
  • 6.3 Clinical Testing
    • 6.3.1 Polymerase Chain Reaction (PCR)
    • 6.3.2 Enzyme Immunoassays (EIAs)
    • 6.3.3 Culture-Based Methods
    • 6.3.4 Rapid Diagnostic Tests
    • 6.3.5 Molecular Assays
  • 6.4 Other Test Types

7 Global E-coli Testing Market, By Technology

  • 7.1 Introduction
  • 7.2 Biosensors
  • 7.3 Chromatography Platforms
  • 7.4 Mass Spectrometry Systems
  • 7.5 Gel Micro Droplets
  • 7.6 Differential Light Scattering
  • 7.7 Flow Cytometry
  • 7.8 Diagnostic Imaging
  • 7.9 Other Technologies

8 Global E-coli Testing Market, By End User

  • 8.1 Introduction
  • 8.2 Diagnostic Laboratories
  • 8.3 Hospitals & Clinics
  • 8.4 Food Processing Companies
  • 8.5 Water Utilities & Wastewater Treatment
  • 8.6 Government & Public Health Agencies
  • 8.7 Research & Academic Institutions
  • 8.8 Physicians' Offices
  • 8.9 Other End Users

9 Global E-coli Testing Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Abbott Laboratories
  • 11.2 Siemens
  • 11.3 Beckman Coulter
  • 11.4 Hoffmann-La Roche
  • 11.5 Wako
  • 11.6 Cepheid
  • 11.7 Becton, Dickinson and Company
  • 11.8 Johnson & Johnson
  • 11.9 Affymetrix
  • 11.10 Novartis
  • 11.11 bioMerieux
  • 11.12 Olympus
  • 11.13 Bio-Rad Laboratories
  • 11.14 GenBio
  • 11.15 Thermo Fisher Scientific

List of Tables

  • Table 1 Global E-coli Testing Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global E-coli Testing Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global E-coli Testing Market Outlook, By Consumables (2024-2032) ($MN)
  • Table 4 Global E-coli Testing Market Outlook, By Instruments (2024-2032) ($MN)
  • Table 5 Global E-coli Testing Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 6 Global E-coli Testing Market Outlook, By Test Type (2024-2032) ($MN)
  • Table 7 Global E-coli Testing Market Outlook, By Environmental Testing (2024-2032) ($MN)
  • Table 8 Global E-coli Testing Market Outlook, By Water Testing (2024-2032) ($MN)
  • Table 9 Global E-coli Testing Market Outlook, By Membrane Filtration (2024-2032) ($MN)
  • Table 10 Global E-coli Testing Market Outlook, By Multiple Tube Fermentation (MTF) (2024-2032) ($MN)
  • Table 11 Global E-coli Testing Market Outlook, By Enzyme Substrate Methods (2024-2032) ($MN)
  • Table 12 Global E-coli Testing Market Outlook, By Food & Beverage Testing (2024-2032) ($MN)
  • Table 13 Global E-coli Testing Market Outlook, By Animal Feed & Livestock Testing (2024-2032) ($MN)
  • Table 14 Global E-coli Testing Market Outlook, By Clinical Testing (2024-2032) ($MN)
  • Table 15 Global E-coli Testing Market Outlook, By Polymerase Chain Reaction (PCR) (2024-2032) ($MN)
  • Table 16 Global E-coli Testing Market Outlook, By Enzyme Immunoassays (EIAs) (2024-2032) ($MN)
  • Table 17 Global E-coli Testing Market Outlook, By Culture-Based Methods (2024-2032) ($MN)
  • Table 18 Global E-coli Testing Market Outlook, By Rapid Diagnostic Tests (2024-2032) ($MN)
  • Table 19 Global E-coli Testing Market Outlook, By Molecular Assays (2024-2032) ($MN)
  • Table 20 Global E-coli Testing Market Outlook, By Other Test Types (2024-2032) ($MN)
  • Table 21 Global E-coli Testing Market Outlook, By Technology (2024-2032) ($MN)
  • Table 22 Global E-coli Testing Market Outlook, By Biosensors (2024-2032) ($MN)
  • Table 23 Global E-coli Testing Market Outlook, By Chromatography Platforms (2024-2032) ($MN)
  • Table 24 Global E-coli Testing Market Outlook, By Mass Spectrometry Systems (2024-2032) ($MN)
  • Table 25 Global E-coli Testing Market Outlook, By Gel Micro Droplets (2024-2032) ($MN)
  • Table 26 Global E-coli Testing Market Outlook, By Differential Light Scattering (2024-2032) ($MN)
  • Table 27 Global E-coli Testing Market Outlook, By Flow Cytometry (2024-2032) ($MN)
  • Table 28 Global E-coli Testing Market Outlook, By Diagnostic Imaging (2024-2032) ($MN)
  • Table 29 Global E-coli Testing Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 30 Global E-coli Testing Market Outlook, By End User (2024-2032) ($MN)
  • Table 31 Global E-coli Testing Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
  • Table 32 Global E-coli Testing Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 33 Global E-coli Testing Market Outlook, By Food Processing Companies (2024-2032) ($MN)
  • Table 34 Global E-coli Testing Market Outlook, By Water Utilities & Wastewater Treatment (2024-2032) ($MN)
  • Table 35 Global E-coli Testing Market Outlook, By Government & Public Health Agencies (2024-2032) ($MN)
  • Table 36 Global E-coli Testing Market Outlook, By Research & Academic Institutions (2024-2032) ($MN)
  • Table 37 Global E-coli Testing Market Outlook, By Physicians' Offices (2024-2032) ($MN)
  • Table 38 Global E-coli Testing Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.